WPHM — Winston Pharmaceuticals Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Winston Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2006 September 30th | 2007 September 30th | 2008 December 31st | 2009 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 0 | 0 | 0.453 | 1.39 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Depreciation and Amortization | ||||
Total Operating Expenses | 0.425 | 0.215 | 5.69 | 4.14 |
Operating Profit | -0.425 | -0.215 | -5.23 | -2.74 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -0.464 | -0.18 | -5.14 | -2.66 |
Provision for Income Taxes | ||||
Net Income After Taxes | -0.464 | -0.18 | -5.14 | -2.66 |
Net Income Before Extraordinary Items | ||||
Net Income | -0.464 | -0.18 | -5.14 | -2.66 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Dilution Adjustment | ||||
Diluted Net Income | -0.464 | -0.18 | -5.14 | -2.66 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.764 | -0.109 | -0.096 | -0.043 |
Dividends per Share |